CELLIMA Scientific Services’ Post

Cellular in vitro models are crucial in preclinical research for understanding the pathologies and development of new drugs. However, due to the complex nature of the human body, obtaining accurate cell models can be difficult.   Tebubio, our European distributor, is delivering a webinar on the challenges of in vitro models, exploring the advantages of consolidating biological sample sourcing with a single, reliable partner, and sharing insights into the comprehensive solutions available for cultivating pertinent cellular models.   📅Tuesday 25th June 🕐10:00am BST | 11:00am CEST 💻Register here: https://rb.gy/3j3zel   #CellularResearch #InVitroModels #ResearchEfficiency

Discover how organoids bridge the gap between the lab and clinic Developing new drugs is a complex and often lengthy process. A major roadblock lies in the limitations of traditional preclinical models, which often fail to accurately represent the intricate biology of human patients. Join DDW for a free event on 18 June, 3PM BST to learn more about how patient-derived organoids are revolutionising drug discovery. https://lnkd.in/eEC865ka #Organoids #DrugDiscovery #LifeSciences HUB Organoids

Our latest review on 3D Imaging is now available! We describe, how light sheet microscopy is transforming drug discovery, with examples from a range of diseases. 🔬 #DrugDiscovery #3DImaging #LightSheetMicroscopy #Research

We are happy to share an in-depth review article, authored by Gubra scientists and available now at #DrugDiscoveryToday, on the possibilities offered by 3D light sheet fluorescence microscopy in preclinical and clinical drug discovery process. Read and download the full paper here: https://lnkd.in/dGzCDTzN #LSFM #PreclinicalImaging #DrugDiscovery

🌟 Meet our new community member: Ary Marsee from HepX Predict! 🌱 Last week, we kicked off our Science and Life Science Validation program. Stay tuned as we introduce our incredible lineup over the coming weeks! HepX Predict is revolutionizing drug development with patented 3D liver organoid technology. By bridging the gap between pre-clinical studies and clinical success, they're tackling the challenge of drug failures head-on. With 70-80% of drugs failing in human trials due to ineffective preclinical models, and liver toxicity contributing to over 20% of these failures, the need for accurate in vitro models is more crucial than ever. Here's to a future of safer and more effective drugs! 💊✨ #DrugDevelopment #Innovation #LifeScience

🚨 Excited to share a new addition to my drug analysis for schizophrenia: NMRA-266, an experimental drug currently on clinical hold due to preclinical data showing it caused convulsions in rabbits. Currently, I give it a 2/5* rating. Curious how it stacks up against other drug candidates? Compare and contrast key data points using my interactive table - link in the comments! #schizophrenia #drugdevelopment #biotech #experimentalDrugs #research #analysis

If you're looking for rapid maturation times and functional iPSC-derived cells, let's have a conversation. In vitro drug discovery is fast-paced; speedier results mean quicker iterations, nimble operations and fewer steps to success, all while saving money. That's why we've developed our axoCells range for fast maturation to robust, functional end point cells. Take a look at the graphic to see the maturation times for our axoCells™ neurons, neuroinflammatory cells and cardiomyocytes. Explore our axoCells Catalog to see the data, applications and product information for our leading axoCells range: https://lnkd.in/epUnnZWt #iPSCs #StemCells #biopharma

Revolutionizing Target Discovery and Precision Medicine with Cell-Based Phage Display! Unlocking the potential of novel therapeutics and diagnostics demands precise targeting of disease-specific molecules. Cell-based phage display offers a powerful solution, enabling the identification of high-affinity peptides that bind to targets in their natural cellular context. This innovative technology streamlines drug discovery, diagnostics development, and fundamental research across various therapeutic areas. Read our latest blog post to learn how Biosynth is leveraging cell-based phage display to accelerate the development of targeted therapies and precision medicine tools. https://lnkd.in/ese4CMfW #phageDisplay #biotechnology #drugdiscovery #diagnostics #precisionmedicine #innovation #Biosynth

𝗗𝗲𝗺𝘆𝘀𝘁𝗶𝗳𝘆𝗶𝗻𝗴 𝗧𝗵𝗲 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗕𝗲𝘁𝘄𝗲𝗲𝗻 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝘃𝘀. 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 https://lnkd.in/d-aCp5Ad 👨🔬 of @Eugenio Fava from @DZNE sharing some great practical insights into recent developments in #neuroscience and early drug discovery ✨

What Role Does #LiveCellImaging Play in Drug Discovery and Disease Modeling? The rise in incidences of cancer significantly contributes to the growth of the live cell imaging market owing to its critical role in #cancerresearch, #diagnosis, and #treatment development. technological advancements serve as a significant driver, continually enhancing imaging modalities, #microscopy techniques and #software solutions. These innovations elevate the precision, resolution, and speed of live cell imaging, empowering researchers to explore cellular processes in real-time with exceptional detail. #Livecellimaging plays a pivotal role in drug discovery, disease modeling, and understanding cellular responses to #therapeutic interventions. Key Market Players: Nikon, Bruker, Thermo Fisher Scientific. , Danaher Corporation, Sartorius AG Microsites Start A Misson, Agilent Technologies, PerkinElmer., Etaluma, Inc., ZEISS Group, Merck KGaA Pharmaceutical Explore More Insight: https://lnkd.in/d3GW-wMJ #LiveCellImaging #CancerResearch #TechnologicalAdvancements #Microscopy #DrugDiscovery #DiseaseModeling #CellularResponses #TherapeuticInterventions #PrecisionImaging #RealTimeAnalysis